The primary objective of this study was to compare blood glucose (BG) excursions between East Asian and Caucasian patients with type 2 diabetes mellitus (T2DM) who were injection-naive, had inadequate glycemic control with oral antihyperglycemic medications, and who required initiation with injectable therapy.
| INTRODUCTION
High glycemic variability is common among patients with type 2 diabetes mellitus (T2DM) 1 and is a key contributor to complications associated with inadequate glycemic control. 2, 3 The assessment of postprandial blood glucose (BG) for management of hyperglycemia in patients with T2DM is well recognized, and guidelines now recommend targeting both pre-and postprandial BG to maintain effective glycemic control. 3 However, ethnic differences in the glycemic response and pathophysiology of T2DM may have implications for how T2DM is managed among different populations and for treatment outcomes. [4] [5] [6] [7] The prevalence of T2DM in Asian populations has increased rapidly in recent years and is associated with high levels of morbidity and mortality. 8 This increase is partly due to changes in lifestyles and diet, earlier onset of T2DM among these populations, and differences in insulin secretion and resistance compared with Caucasian populations. [4] [5] [6] [7] In addition, evidence from studies in healthy subjects suggests that the carbohydrate-rich traditional Asian diet contributes to hyperglycemia 9 and that postprandial hyperglycemia in response to the same glycemic load is higher in Asians than in Caucasians. 4 Consequently, studies conducted in Asian patients with T2DM have shown postprandial BG to be important for management of hyperglycemia in patients on oral antihyperglycemic medication (OAM) 10 or insulin. 11 Despite this, few studies have directly compared BG profiles between Asian and Caucasian patients with T2DM. 12 Findings from a post hoc subgroup analysis of data from a large clinical trial (PARADIGM) of insulin-naive patients with T2DM 13 suggest that East Asian patients who have not started injectable therapy have higher postprandial BG excursions than Caucasian patients. 12 However, this study was not designed to assess the possible effect of race or ethnicity on BG profiles before insulin initiation and statistical analysis of the differences in postprandial BG excursion between ethnic groups was not reported.
The primary objective of this study was to compare BG excursions between East Asian and Caucasian patients with T2DM who were injection-naive, had inadequate glycemic control with OAMs, and who required initiation with injectable therapy. To address this objective, we conducted a retrospective pooled analysis of individual patient data from clinical trials including East Asian and/or Caucasian patients from two Eli Lilly sponsored programs. In addition, we conducted a systematic review of the peer-reviewed literature with published summary data to identify studies reporting baseline BG or BG excursion data for patients who met the inclusion criteria. for inclusion if they met the following criteria: first patient visit was on or after 1997; enrolled male or female adult (≥18 years) patients with T2DM who were injection-naive (or had completed a sufficient washout period per individual study requirements); had inadequate glycemic control with OAMs, and required initiation with injectable therapy; and had baseline data for self-monitored blood glucose (SMBG). As only baseline data were included in the analyses, there were no restrictions on study interventions or treatment duration. The primary outcome was BG excursion defined as the difference between preprandial and postprandial BG at breakfast. Secondary outcomes included BG excursion at lunch and dinner, and the daily average BG excursion.
| Baseline and analysis variables

| Statistical analysis
The full analysis set included all eligible randomized patients or all eligible enrolled patients from nonrandomized studies. Mean BG excursion at baseline was compared between East Asian and Caucasian patients using an analysis of covariance. The model included race as the fixed effect and baseline body weight, baseline HbA1c, age, and duration of T2DM as covariates. There was no imputation for missing BG measurements. Data were reported as mean (standard deviation) or least-squares mean (standard error of the mean). Statistical analyses were conducted using SAS® Version 9.4 (SAS Institute, Cary, NC, USA).
| Systematic review
The methodology for the systematic review is reported in the Supplementary Appendix. patients to have HbA1c >7% at baseline (Table 1) . Patients had been diagnosed with T2DM for an average of 8.9 years and had mean HbA1c levels >7% at baseline (Table 2) . However, there were significant differences between the East Asian and Caucasian groups. Compared with the Caucasian group, there was a significantly higher proportion of men in the East Asian group, and patients were significantly younger, with significantly lower body weight, body mass index, and HbA1c levels ( Table 2 ).
| Blood glucose
BG excursions were highest after breakfast in both populations when adjusted for baseline body weight, baseline HbA1c, age, and duration of T2DM, and were significantly higher for East Asian patients than for Caucasian patients (Figure 1 , Table 3 ). In addition, BG excursions were significantly higher for East Asian patients than Caucasian patients at lunch, and dinner, and for the daily average (Figure 1) . Similar findings were observed for the unadjusted analyses (Table 3 ).
BG profiles were significantly different between East Asian and Caucasian patients ( Figure 2 , Table 3 ). In the unadjusted analysis, preprandial BG was significantly lower and postprandial BG was significantly higher for East Asian patients than for Caucasian patients at all time points (Figure 2A ). The differences in preprandial BG at lunch, dinner, and for the daily preprandial average between East Asian and Caucasian patients were not significant when the analyses were adjusted for baseline body weight, baseline HbA1c, age, and duration of T2DM. However, differences between East Asian and Caucasian patients in all postprandial BG levels remained significant after adjustment for these factors ( Figure 2B , Table 3 ).
| Systematic review of the literature
Five publications met the eligibility criteria for the systematic review;
four studies reported findings in Caucasian populations [14] [15] [16] [17] and one T2DM who were insulin-naive has shown that the contribution of postprandial BG to excess hyperglycemia decreases relative to fasting BG in poorly controlled patients. 24 In contrast, several studies have shown that targeting postprandial BG is as important as targeting preprandial BG for management of hyperglycemia among East Asian patients who are poorly controlled on OAMs, before receiving injectable treatment 10 and among those on insulin. 10, 11 Analysis of Asian patients with T2DM who were insulin-naive has shown that the contribution of postprandial BG to 4-hour excess hyperglycemia after meals and 24-hour excess hyperglycemia is similar to the contribution of preprandial BG/fasting BG, respectively, in poorly controlled patients (HbA1c >7%). 10 In addition, findings from a retrospective post hoc analysis of patients with T2DM of different ethnicities showed that Asian patients had a greater need for, and higher doses of, mealtime insulin than non-Asian patients on basal insulin glargine plus prandial insulin lispro. 12 Together with the current study, these findings suggest that postprandial BG is an important treatment target in East Asian populations and suggests that East Asian patients may have a greater and earlier need of therapies. Indeed, assessment of treatment patterns from noninterventional studies has shown that use of premixed insulins in Asian populations is widespread, with approximately one-third of Japanese patients commencing insulin with a premixed insulin 25 and approximately two-thirds of Chinese patients on OAMs using a premixed insulin. 26 
FIGURE 2
Pooled analysis of blood glucose profiles for East Asian and Caucasian injection-naive patients with inadequate glycemic control after oral antihyperglycemic medication. A, Unadjusted mean preprandial and postprandial blood glucose at each time point. B, Adjusted least-squares mean preprandial and postprandial blood glucose at each time point. Error bars are not visible as they are within the symbols for each data point. Unadjusted preprandial and postprandial blood glucose and adjusted postprandial blood glucose were significantly different between Caucasians and East Asians at all time points (*P < 0.001, ANCOVA); adjusted prebreakfast blood glucose was significantly higher in Caucasians than in East Asians (P = 0.048)
The main strength of this study was the large number of patients available for analysis from multiple clinical studies with similar eligibility criteria and procedures. Significant differences in BG profiles and excursions between the East Asian and Caucasian groups were observed in the unadjusted analyses and after analyses were adjusted to take into account differences in baseline characteristics between the groups. However, interpretation of the findings should take into account the retrospective nature of the analyses and that the included studies were not designed to compare BG profiles of patients from different ethnicities. As this was a post-hoc pooled analysis, our intention was to show whether there were differences in BG profiles between the two ethnic groups. We did not match the baseline characteristics and demographics between East Asian and Caucasian patients. Therefore, it was impossible to explore the reasons for the differences observed in this study. Although the included clinical studies were very similar in design, the interpretation of the findings should take into account that data were pooled data from two clinical trial programs that were conducted at different times, and that included patients with various OAM treatment regimens, and patients from different Caucasian populations. The systematic review of the literature confirmed the rationale for conducting a pooled analysis and showed that there is limited information in the peer-reviewed literature on postprandial BG before commencing injectable treatment.
Moreover, there was a high degree of variability in the data available from the peer-reviewed literature; only one study included data on BG excursion at baseline and only one study reported on BG excursions in East Asian patients.
In conclusion, findings from this retrospective pooled analysis of individual patient data showed significantly higher postprandial BG excursions in East Asian patients with T2DM who were injection-naive and had inadequate glycemic control with OAMs compared with Caucasian patients. These findings have clinical implications for the effect of ethnicity on the BG profiles in patients with T2DM and suggest that there should be greater emphasis on the control of BG excursions in East Asian patients. In addition, these findings may help clinicians select appropriate treatments for East Asian patients with T2DM who require injection therapy.
